Search research articles
Contact Us
Filters
Showing results (301-310 of 344) with videos related to
Page
of 35
Sort By:
JCO Oncology Practice
|
December 19, 2025
Durable Complete Response and Potential Cure With Systemic Chemotherapy in Metastatic Gastric Cancer: A Case Series of Patients
Shinpei Ushiyama, Takumi Habu, Izuma Nakayama, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 15, 2023
Health-Related Quality of Life With Nivolumab Plus Chemotherapy Versus Chemotherapy in Patients With Advanced Gastric/Gastroesophageal Junction Cancer or Esophageal Adenocarcinoma From CheckMate 649
Markus Moehler, Hong Xiao, Steven I Blum, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
November 2, 2020
Effect of early tumor response on the health-related quality of life among patients on second-line chemotherapy for advanced gastric cancer in the ABSOLUTE trial
Kazumasa Fujitani, Kohei Shitara, Atsuo Takashima, et al.
Annals of Surgery
|
March 21, 2025
Circulating Tumor DNA Assessment to Predict Risk of Recurrence after Surgery in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma: A Prospective Observational Study
Shogo Takei, Daisuke Kotani, George Laliotis, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
June 2, 2018
Peritoneal metastasis as a predictive factor for nab-paclitaxel in patients with pretreated advanced gastric cancer: an exploratory analysis of the phase III ABSOLUTE trial
Atsuo Takashima, Kohei Shitara, Kazumasa Fujitani, et al.
JAMA Oncology
|
April 1, 2021
Assessment of Pembrolizumab Therapy for the Treatment of Microsatellite Instability-High Gastric or Gastroesophageal Junction Cancer Among Patients in the KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062 Clinical Trials
Joseph Chao, Charles S Fuchs, Kohei Shitara, et al.
Nature Communications
|
November 2, 2025
Modeling and addressing on-target/off-tumor toxicity of claudin 18.2 targeted immunotherapies
Elizabeth J Carstens, Kazuki Takahashi, Naoya Sakamoto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 14, 2022
Randomized, Double-Blind, Placebo-Controlled Phase III Study of Paclitaxel ± Napabucasin in Pretreated Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
Manish A Shah, Kohei Shitara, Florian Lordick, et al.
Cancer Science
|
May 21, 2026
Neutrophil-Macrophage Interactions Shape Inflammatory Macrophage Remodeling in Gastric Cancer During Chemo-Immunotherapy
Keita H Nagaoka, Hiroki Yamashita, Chiaki Mashima, et al.
Cancer Science
|
May 21, 2026
A cDC1-NK/T-Malignant Cell Circuit Drives Immunogenic Remodeling Under PD-1 Blockade in Gastric Cancer
Takuya Nakatsuru, Hiroki Yamashita, Chiaki Mashima, et al.
Page
of 35
Search research articles
Search
Showing results (301-310 of 344) with videos related to
Sort By:
Page
of 35
JCO Oncology Practice
|
December 19, 2025
Durable Complete Response and Potential Cure With Systemic Chemotherapy in Metastatic Gastric Cancer: A Case Series of Patients
Shinpei Ushiyama, Takumi Habu, Izuma Nakayama, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 15, 2023
Health-Related Quality of Life With Nivolumab Plus Chemotherapy Versus Chemotherapy in Patients With Advanced Gastric/Gastroesophageal Junction Cancer or Esophageal Adenocarcinoma From CheckMate 649
Markus Moehler, Hong Xiao, Steven I Blum, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
November 2, 2020
Effect of early tumor response on the health-related quality of life among patients on second-line chemotherapy for advanced gastric cancer in the ABSOLUTE trial
Kazumasa Fujitani, Kohei Shitara, Atsuo Takashima, et al.
Annals of Surgery
|
March 21, 2025
Circulating Tumor DNA Assessment to Predict Risk of Recurrence after Surgery in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma: A Prospective Observational Study
Shogo Takei, Daisuke Kotani, George Laliotis, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
June 2, 2018
Peritoneal metastasis as a predictive factor for nab-paclitaxel in patients with pretreated advanced gastric cancer: an exploratory analysis of the phase III ABSOLUTE trial
Atsuo Takashima, Kohei Shitara, Kazumasa Fujitani, et al.
JAMA Oncology
|
April 1, 2021
Assessment of Pembrolizumab Therapy for the Treatment of Microsatellite Instability-High Gastric or Gastroesophageal Junction Cancer Among Patients in the KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062 Clinical Trials
Joseph Chao, Charles S Fuchs, Kohei Shitara, et al.
Nature Communications
|
November 2, 2025
Modeling and addressing on-target/off-tumor toxicity of claudin 18.2 targeted immunotherapies
Elizabeth J Carstens, Kazuki Takahashi, Naoya Sakamoto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 14, 2022
Randomized, Double-Blind, Placebo-Controlled Phase III Study of Paclitaxel ± Napabucasin in Pretreated Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
Manish A Shah, Kohei Shitara, Florian Lordick, et al.
Cancer Science
|
May 21, 2026
Neutrophil-Macrophage Interactions Shape Inflammatory Macrophage Remodeling in Gastric Cancer During Chemo-Immunotherapy
Keita H Nagaoka, Hiroki Yamashita, Chiaki Mashima, et al.
Cancer Science
|
May 21, 2026
A cDC1-NK/T-Malignant Cell Circuit Drives Immunogenic Remodeling Under PD-1 Blockade in Gastric Cancer
Takuya Nakatsuru, Hiroki Yamashita, Chiaki Mashima, et al.
Page
of 35